Insider Trading & Ownership - enVVeno Medical Corp (NVNO)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for enVVeno Medical Corp
Goto 0, 1, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-03-13
Sale
2024-03-15
8:00 pm
enVVeno Medical CorpNVNOAlavi Hamed
Chief Technology Officer
8,334$6.22$51,83791,666
(Direct)
View
2022-08-16
Purchase
2022-08-18
4:05 pm
enVVeno Medical CorpNVNODuhay Francis
Director
7,751$6.14$47,59120,911
(Direct)
View
2022-06-30
Purchase
2022-07-01
4:05 pm
enVVeno Medical CorpNVNOShrivastava Sanjay
Director
1,000$3.85$3,8503,888
(Direct)
View
2022-06-27
Purchase
2022-06-28
4:05 pm
enVVeno Medical CorpNVNOBERMAN ROBERT ANDREW
Chief Executive Officer
2,500$3.8$9,500210,236
(Direct)
View
2021-11-19
Purchase
2021-11-19
5:27 pm
enVVeno Medical CorpNVNOBERMAN ROBERT ANDREW
CEO
2,000$7.43$14,8607,736
(Direct)
View
2021-11-16
Purchase
2021-11-18
4:24 pm
enVVeno Medical CorpNVNOBERMAN ROBERT ANDREW
CEO
2,000$7.87$15,7405,736
(Direct)
View
2021-08-25
Purchase
2021-08-27
3:19 pm
Hancock Jaffe Laboratories Inc.HJLIJenusaitis Matthew
Director
1,300$7.7$10,0104,842
(Direct)
View
2021-06-16
Purchase
2021-06-21
7:16 pm
Hancock Jaffe Laboratories Inc.HJLIGray Robert
Director
2,000$6.25$12,5005,572
(Direct)
View
2021-05-21
Purchase
2021-05-25
5:15 pm
Hancock Jaffe Laboratories Inc.HJLIGlickman Marc H.
SVP & Chief Medical Officer
1,600$5.9$9,4401,600
(Direct)
View
2021-05-18
Purchase
2021-05-19
8:20 pm
Hancock Jaffe Laboratories Inc.HJLIBERMAN ROBERT ANDREW
Chief Executive Officer
3,000$5.47$16,4103,736
(Direct)
View
2021-05-17
Purchase
2021-05-19
8:18 pm
Hancock Jaffe Laboratories Inc.HJLIDuhay Francis
Director
9,492$5.33$50,59213,160
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-03-13
Exercise
2024-03-15
8:00 pm
N/A
2033-12-05
enVVeno Medical CorpNVNOAlavi Hamed
Chief Technology Officer
8,334$091,666
(Direct)
View
2024-03-13
Exercise
2024-03-15
8:00 pm
N/A
N/A
enVVeno Medical CorpNVNOAlavi Hamed
Chief Technology Officer
8,334$3.5991,666
(Direct)
View
2023-12-05
Option Award
2023-12-07
5:07 pm
N/A
2033-12-05
enVVeno Medical CorpNVNOGlynn Craig
Chief Financial Officer
75,000$075,000
(Direct)
View
2023-12-05
Option Award
2023-12-07
5:06 pm
N/A
2033-12-05
enVVeno Medical CorpNVNOJenusaitis Matthew
Director
13,856$013,856
(Direct)
View
2023-12-05
Option Award
2023-12-07
5:05 pm
N/A
2033-12-05
enVVeno Medical CorpNVNOAlavi Hamed
Chief Technology Officer
100,000$0100,000
(Direct)
View
2023-12-05
Option Award
2023-12-07
5:05 pm
N/A
2033-12-05
enVVeno Medical CorpNVNOGlickman Marc H.
SVP & Chief Medical Officer
100,000$0100,000
(Direct)
View
2023-12-05
Option Award
2023-12-07
5:05 pm
N/A
2033-12-05
enVVeno Medical CorpNVNOGray Robert
Director
13,856$013,856
(Direct)
View
2023-12-05
Option Award
2023-12-07
5:05 pm
N/A
2033-12-05
enVVeno Medical CorpNVNOShrivastava Sanjay
Director
13,856$013,856
(Direct)
View
2023-12-05
Option Award
2023-12-07
5:05 pm
N/A
2033-12-05
enVVeno Medical CorpNVNODuhay Francis
Director
13,856$013,856
(Direct)
View
2023-12-05
Option Award
2023-12-07
5:05 pm
N/A
2033-12-05
enVVeno Medical CorpNVNOBERMAN ROBERT ANDREW
Chief Executive Officer
300,000$0300,000
(Direct)
View

Ownership
2023-01-31
9:56 pm
N/A
2032-11-30
enVVeno Medical CorpNVNOAlavi Hamed
Chief Technology Officer
0$0603,925
(Direct)
View
2022-11-30
Option Award
2022-12-02
4:30 pm
N/A
2032-11-30
enVVeno Medical CorpNVNOJenusaitis Matthew
Director
8,403$08,403
(Direct)
View
2022-11-30
Option Award
2022-12-02
4:30 pm
N/A
2032-11-30
enVVeno Medical CorpNVNOShrivastava Sanjay
Director
8,403$08,403
(Direct)
View
2022-11-30
Option Award
2022-12-02
4:30 pm
N/A
2032-11-30
enVVeno Medical CorpNVNOGray Robert
Director
8,403$08,403
(Direct)
View
2022-11-30
Option Award
2022-12-02
4:30 pm
N/A
2032-11-30
enVVeno Medical CorpNVNODuhay Francis
Director
8,403$08,403
(Direct)
View
2022-09-13
Exercise
2022-09-16
4:05 pm
N/A
N/A
enVVeno Medical CorpNVNOGray Robert
Director
1,041$07,655
(Direct)
View
2022-09-13
Exercise
2022-09-16
4:05 pm
N/A
N/A
enVVeno Medical CorpNVNOJenusaitis Matthew
Director
1,041$06,925
(Direct)
View
2021-11-30
Option Award
2021-12-02
6:27 pm
N/A
2031-11-30
enVVeno Medical CorpNVNOBERMAN ROBERT ANDREW
Chief Executive Officer
549,781$0557,517
(Direct)
View
2021-11-30
Option Award
2021-12-02
6:26 pm
N/A
2031-11-30
enVVeno Medical CorpNVNOGlickman Marc H.
SVP & Chief Medical Officer
365,700$0367,300
(Direct)
View
2021-11-30
Option Award
2021-12-02
6:25 pm
N/A
2031-11-30
enVVeno Medical CorpNVNOGlynn Craig
Chief Financial Officer
175,925$0175,925
(Direct)
View
2021-11-30
Option Award
2021-12-02
4:05 pm
N/A
2031-11-30
enVVeno Medical CorpNVNOGray Robert
Director
7,211$07,211
(Direct)
View
2021-11-30
Option Award
2021-12-02
4:05 pm
N/A
2031-11-30
enVVeno Medical CorpNVNODuhay Francis
Director
7,211$07,211
(Direct)
View
2021-11-30
Option Award
2021-12-02
4:05 pm
N/A
2031-11-30
enVVeno Medical CorpNVNOJenusaitis Matthew
Director
7,211$07,211
(Direct)
View
2021-11-30
Option Award
2021-12-02
4:05 pm
N/A
2031-11-30
enVVeno Medical CorpNVNOShrivastava Sanjay
Director
7,211$07,211
(Direct)
View
2021-11-16
Exercise
2021-11-18
4:30 pm
N/A
N/A
enVVeno Medical CorpNVNOShrivastava Sanjay
Director
388$02,888
(Direct)
View
2021-09-13
Exercise
2021-09-15
9:50 pm
N/A
N/A
Hancock Jaffe Laboratories Inc.HIJIJenusaitis Matthew
Director
1,042$07,968
(Direct)
View
2021-09-13
Exercise
2021-09-15
9:50 pm
N/A
N/A
Hancock Jaffe Laboratories Inc.HIJIGray Robert
Director
1,042$08,698
(Direct)
View
2020-07-18
Option Award
2021-02-23
5:21 pm
N/A
2030-07-18
Hancock Jaffe Laboratories Inc.HJLIGlynn Craig
Chief Financial Officer
328,000$04,324
(Direct)
View
2021-02-18
Option Award
2021-02-22
9:59 pm
N/A
2031-02-18
Hancock Jaffe Laboratories Inc.HJLIDuhay Francis
Director
5,673$05,673
(Direct)
View
2021-02-18
Option Award
2021-02-22
9:58 pm
N/A
2031-02-18
Hancock Jaffe Laboratories Inc.HJLIJenusaitis Matthew
Director
5,673$05,673
(Direct)
View
Goto 0, 1, Next